←
Mark Hartmann350 posts
Mark Hartmann avatar

Mark Hartmann

@mp_hartmann

Scientist @DKFZ @NCT_HD @TMO_Heidelberg @TransCanEpi #epigenetics #stemcells #leukemia #multiomics #precisiononcology #oncofetal #reprogramming #plasticity

◷ Joined November 2020▧ 42 Photos and videos
Mark Hartmann avatar
Mark Hartmann@mp_hartmann·Oct 17

Each molecular layer adds a different perspective. This single-patient proof of concept shows how simultaneous multi-omics connects CTC identity with heterogeneity—and reveals where genetic, epigenetic and transcriptional patterns agree or diverge.

Post attachment
Mark Hartmann avatar
Mark Hartmann@mp_hartmann·Oct 17

Genetic and epigenetic profiles largely agreed, revealing two CTC subpopulations. Transcriptomes supported neuroendocrine identity but did not clearly separating these epi-/genetic clusters.

Post attachment
Mark Hartmann avatar
Mark Hartmann@mp_hartmann·Oct 17

Which rare circulating cells are tumour cells? In a patient with metastatic cervical small-cell neuroendocrine carcinoma, tumour-matched genetic alterations and complementary methylation and RNA profiles established CTC identity.

Post attachment
Mark Hartmann avatar
Mark Hartmann@mp_hartmann·Jul 23

Check out our latest preprint on epigenetic classification of leukemias!

‼️ Pre-print alert from the Lipka lab ‼️ Our latest work “Hierarchical classification of hematologic malignancies using epigenetic and genetic information” is now online! biorxiv.org/content/10.64898… Thanks to all colleagues who contributed to this work! 🙏

Mark Hartmann avatar
Mark Hartmann@mp_hartmann·Apr 9

Editors’ Pick by Cancer Research Catalyst @AACR RAS-driven plasticity and oncofetal reprogramming as a key mechanism and vulnerability in JMML. The article is freely available for a limited time: aacr.org/blog/2026/03/27/edi… #hematology #oncology #epigenetics #development

Mark Hartmann avatar
Mark Hartmann@mp_hartmann·Apr 2

Excited to share our work at the 2026 #ISEH Mini Symposium! "Beyond the maturation block: oncofetal reprogramming & stem cell plasticity in pediatric leukemia" Great lineup incl. @beth_psaila, Simón Méndez-Ferrer & Jian Xu Join us April 16: iseh.org/Webinars-Events/Min… @ISEHSociety

We are excited to announce the full Mini Symposium program featuring the short talks selected from submitted abstracts! Don't miss the chance to view groundbreaking research and choose the top short talk. View the full program and register ➡️ iseh.org/Webinars-Events/Min…

Post attachment
Blood Cancer Discovery avatar
⟳ Mark Hartmann retweeted
Blood Cancer Discovery@BCD_AACR·Mar 31

Read the March Editors' Pick: Molecular Plasticity Results in Oncofetal Reprogramming and Therapeutic Vulnerabilities in Juvenile Myelomonocytic Leukemia doi.org/10.1158/2643-3230.BC…

AACR@AACRMar 30

The March edition of Editors’ Picks from AACR journals includes studies on pediatric leukemia development, awareness of alcohol as a carcinogen, and more. Learn more on the #AACRBlog: brnw.ch/21x1aEw

Post attachment
AACR avatar
⟳ Mark Hartmann retweeted
AACR@AACR·Mar 30

The March edition of Editors’ Picks from AACR journals includes studies on pediatric leukemia development, awareness of alcohol as a carcinogen, and more. Learn more on the #AACRBlog: brnw.ch/21x1aEw

Post attachment
Rhys Morgan avatar
⟳ Mark Hartmann retweeted
Rhys Morgan@RhysMorganLab·Feb 9

We're hiring a new 3 yr postdoc! Come join us at @SussexUni for exciting new @CR_UK funded project targeting RUNX1 mutations in CML in a highly supportive research environment within @Sussex_BCR @SussexLifeSci @BiochemBiomedUS @Sussex_Cancer Apply 👇, advert closes 8th March.

New post: Research Fellow in Biochemistry & Biomedicine (Fixed Term) Ref: 43139 Closing Date: 08 March 2026 To apply visit: jobs.sussex.ac.uk/job/4fee4e…